Inventor · disambiguated record
Glenn R. Larsen
Also filed as: LARSEN GLENN · LARSEN GLENN R
30 granted patents·21 pending applications·588 citations·filing 1986–2025
97Inventor score
Files withHYDRA BIOSCIENCES INC12GENETICS INST9180 THERAPEUTICS LP7SCPHARMACEUTICALS INC5AQUINNAH PHARMACEUTICALS INC4
Top patents by PatentIndex Score
51 records- 0195US5827817AP-selectin ligand proteinGENETICS INST·Filed 1995·Granted Oct 27, 1998·146 cites·16 claims
- 0293US10272064B2Pharmaceutical formulations for subcutaneous administration of furosemideSCPHARMACEUTICALS INC·Filed 2018·Granted Apr 30, 2019·16 cites·16 claims
- 0392US12370168B2Pharmaceutical formulations for subcutaneous administration of furosemideSCPHARMACEUTICALS INC·Filed 2022·Granted Jul 29, 2025·1 cites·9 claims
- 0492US9884039B2Pharmaceutical formulations for subcutaneous administration of furosemideSCPHARMACEUTICALS INC·Filed 2014·Granted Feb 6, 2018·21 cites·23 claims
- 0592US7893260B2Substituted quinazolin-4-one compounds for antagonizing TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2006·Granted Feb 22, 2011·23 cites·13 claims
- 0692US5840679AMethod of inhibiting P-selectin ligand activityGENETICS INST·Filed 1995·Granted Nov 24, 1998·98 cites·26 claims
- 0791US7998980B2Compounds for modulating TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2007·Granted Aug 16, 2011·15 cites·10 claims
- 0889US7803790B2Compounds for modulating TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2006·Granted Sep 28, 2010·12 cites·10 claims
- 0988US7563760B2P-selectin ligand proteinGENETICS INST LLC·Filed 2001·Granted Jul 21, 2009·23 cites·16 claims
- 1087US5843707ANucleic acid encoding a novel P-selectin ligand proteinGENETICS INST·Filed 1995·Granted Dec 1, 1998·71 cites·27 claims
- 1186US8163761B2Methods and compositions for treating disordersNG HOWARD·Filed 2008·Granted Apr 24, 2012·14 cites·5 claims
- 1286US7198789B2Methods and compositions for modulating interleukin-21 receptor activityGENETICS INST LLC·Filed 2002·Granted Apr 3, 2007·32 cites·66 claims
- 1384US11433044B2Pharmaceutical formulations for subcutaneous administration of furosemideSCPHARMACEUTICALS INC·Filed 2019·Granted Sep 6, 2022·3 cites·20 claims
- 1484US9181219B2Compounds of modulating TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2013·Granted Nov 10, 2015·5 cites·5 claims
- 1584US2025339397A1Pharmaceutical formulations for subcutaneous administration of furosemideSCPHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1682US8916550B2Compounds for modulating TRPV3 functionCHONG JAYHONG A·Filed 2006·Granted Dec 23, 2014·3 cites·26 claims
- 1781US8389546B2Compounds for modulating TRPV3 functionMORAN MAGDALENE M·Filed 2011·Granted Mar 5, 2013·4 cites·14 claims
- 1880US6277975B1Fusions of P-selectin ligand protein and polynucleotides encoding sameGENETICS INST·Filed 1996·Granted Aug 21, 2001·34 cites·16 claims
- 1978US5071972ADNA sequences encoding novel thrombolytic proteinsGENETICS INST·Filed 1987·Granted Dec 10, 1991·40 cites·1 claims
- 2074US11613570B2Method of treating dupuytren's disease using a pre-filled syringe180 THERAPEUTICS LP·Filed 2022·Granted Mar 28, 2023·0 cites·2 claims
- 2174US9486455B2Compounds for modulating TRPV3 functionCHONG JAYHONG A·Filed 2011·Granted Nov 8, 2016·2 cites·13 claims
- 2274US8552009B2Substituted pyrimido 4.5-d pyrimidin-4-one compounds for modulating TRPV3 functionCHONG JAYHONG A·Filed 2011·Granted Oct 8, 2013·2 cites·14 claims
- 2374US2023220060A1Method of treating early stage dupuytren's disease180 THERAPEUTICS LP·Filed 2023·Application pending·0 cites
- 2472US11400154B2Method of treating a localized fibrotic disorder using an IL-33 antagonist180 THERAPEUTICS LP·Filed 2019·Granted Aug 2, 2022·0 cites·18 claims
- 2568US10500273B2Method of treating a localized fibrotic disorder using an IL-33 antagonistLARSEN GLENN·Filed 2016·Granted Dec 10, 2019·1 cites·13 claims
- 2667US7927835B2Nucleic acids encoding P-selectin ligand fusion proteinsGENETICS INST LLC·Filed 2008·Granted Apr 19, 2011·0 cites·16 claims
- 2766US2021386855A1Method of treating a localized fibrotic disorder using a tnf receptor 2 antagonist180 THERAPEUTICS LP·Filed 2021·Application pending·0 cites
- 2864US2015299225A1Compounds for modulating trpv3 functionCHONG JAYHONG A·Filed 2014·Application pending·0 cites
- 2963US12344667B2Method of treating early stage Dupuytren's disease180 THERAPEUTICS LP·Filed 2017·Granted Jul 1, 2025·0 cites·2 claims
- 3061US2009018147A1Compounds for modulating TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2008·Application pending·0 cites
- 3160US8232252B2P-selectin ligand proteinLARSEN GLENN R·Filed 2008·Granted Jul 31, 2012·0 cites·14 claims
- 3256US2014155417A1Compounds for modulating trpv3 functionHYDRA BIOSCIENCES INC·Filed 2013·Application pending·0 cites
- 3354US5002887ATruncated thrombolytic proteinsGENETICS INST·Filed 1986·Granted Mar 26, 1991·11 cites·3 claims
- 3453US2016256447A1Compounds for modulating trpv3 functionHYDRA BIOSCIENCES INC·Filed 2015·Application pending·0 cites
- 3552US2018133170A1Methods and compositions for treating disordersHYDRA BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 3651US2017224687A1Compounds for modulating trpv3 functionHYDRA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 3750US2017020858A1Compounds for modulating trpv3 functionHYDRA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 3848US2013059869A1Methods and compositions for treating disordersNG HOWARD·Filed 2012·Application pending·0 cites
- 3948US2010273777A1Compounds for Modulating TRPV3 FunctionHYDRA BIOSCIENCES INC·Filed 2010·Application pending·0 cites
- 4047US5418158ADNA sequences encoding novel thrombolytic proteinsGENETICS INST·Filed 1993·Granted May 23, 1995·8 cites·2 claims
- 4143US2019225682A1Method of treating localized fibrotic disorders using an il-33/tnf bispecific antibody180 THERAPEUTICS LP·Filed 2017·Application pending·0 cites
- 4240US2005261189A1Methods of promoting cardiac cell proliferationHYDRA BIOSCIENCES INC·Filed 2005·Application pending·0 cites
- 4340US2019202907A1Method of treating systemic fibrotic disorders using an il-33/tnf bispecific antibody180 THERAPEUTICS LP·Filed 2017·Application pending·0 cites
- 4440US2006140933A1Compositions and methods for treating rage-associated disordersWYETH AND IMP COLLEGE INNOVATI·Filed 2003·Application pending·0 cites
- 4538US2016158325A1Method of treating fibroproliferative disorders including dupuytren's disease with one or more specific human matrix metalloproteinase and a tnf antagonistLARSEN GLENN·Filed 2014·Application pending·0 cites
- 4637US2019142860A1Nucleic acid based tia-1 inhibitorsAQUINNAH PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4732US2018305334A1Compounds, compositions and methods of use against stress granulesAQUINNAH PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4831US5837518AThrombolytic proteinsGENETICS INST·Filed 1997·Granted Nov 17, 1998·2 cites·6 claims
- 4930US2017369474A1Compounds, compositions and methods of useAQUINNAH PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 5030US2017360726A1Compounds, compositions and methods of useAQUINNAH PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Glenn R. Larsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →